242 related articles for article (PubMed ID: 27123915)
1. Impact of Patient Reimbursement Timing and Patient Out-of-Pocket Expenses on Medication Adherence in Patients Covered by Private Drug Insurance Plans.
Després F; Forget A; Kettani FZ; Blais L
J Manag Care Spec Pharm; 2016 May; 22(5):539-47. PubMed ID: 27123915
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the adherence and persistence to inhaled corticosteroids among adult patients with public and private drug insurance plans.
Cyr MC; Beauchense MF; Lemiere C; Blais L
J Popul Ther Clin Pharmacol; 2013; 20(1):e26-41. PubMed ID: 23392860
[TBL] [Abstract][Full Text] [Related]
3. Impact of drug plans on adherence to and the cost of antihypertensive medications among patients covered by a universal drug insurance program.
Després F; Perreault S; Lalonde L; Forget A; Kettani FZ; Blais L
Can J Cardiol; 2014 May; 30(5):560-7. PubMed ID: 24613090
[TBL] [Abstract][Full Text] [Related]
4. Role of Cost on Failure to Access Prescribed Pharmaceuticals: The Case of Statins.
McRae I; van Gool K; Hall J; Yen L
Appl Health Econ Health Policy; 2017 Oct; 15(5):625-634. PubMed ID: 28660496
[TBL] [Abstract][Full Text] [Related]
5. The impact of the type of insurance plan on adherence and persistence with antidepressants: a matched cohort study.
Assayag J; Forget A; Kettani FZ; Beauchesne MF; Moisan J; Blais L
Can J Psychiatry; 2013 Apr; 58(4):233-9. PubMed ID: 23547647
[TBL] [Abstract][Full Text] [Related]
6. The Economic Burden of Out-of-Pocket Expenses for Plastic Surgery Procedures.
Billig JI; Chen JS; Lu YT; Chung KC; Sears ED
Plast Reconstr Surg; 2020 Jun; 145(6):1541-1551. PubMed ID: 32459783
[TBL] [Abstract][Full Text] [Related]
7. Impact of partial reimbursement on hepatitis B antiviral utilization and adherence.
Qiu Q; Duan XW; Li Y; Yang LK; Chen Y; Li H; Duan ZP; Wang L
World J Gastroenterol; 2015 Aug; 21(32):9588-97. PubMed ID: 26327766
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of Low-Cost Generic Program Use in a Nationally Representative Cohort of Privately Insured Adults.
Pauly NJ; Brown JD
J Manag Care Spec Pharm; 2015 Dec; 21(12):1162-70. PubMed ID: 26679965
[TBL] [Abstract][Full Text] [Related]
9. Evaluating the Impact of Sample Medication on Subsequent Patient Adherence.
Pringle JL; Aldridge A; Kearney SM; Grasso K; Radack J; Hogue S; Manolis C
J Manag Care Spec Pharm; 2016 Nov; 22(11):1262-1269. PubMed ID: 27783544
[TBL] [Abstract][Full Text] [Related]
10. Impact of Out-of-Pocket Pharmacy Costs on Branded Medication Adherence Among Patients with Type 2 Diabetes.
Bibeau WS; Fu H; Taylor AD; Kwan AY
J Manag Care Spec Pharm; 2016 Nov; 22(11):1338-1347. PubMed ID: 27783549
[TBL] [Abstract][Full Text] [Related]
11. Evaluating the relationship between quality measure adherence definitions and economic outcomes in commercial health plans: a retrospective diabetes cohort study.
Chinthammit C; Axon DR; Mollon L; Taylor AM; Pickering M; Black H; Warholak T; Campbell PJ
J Manag Care Spec Pharm; 2021 Jan; 27(1):64-72. PubMed ID: 33377445
[No Abstract] [Full Text] [Related]
12. Association of Branded Prescription Drug Rebate Size and Patient Out-of-Pocket Costs in a Nationally Representative Sample, 2007-2018.
Yeung K; Dusetzina SB; Basu A
JAMA Netw Open; 2021 Jun; 4(6):e2113393. PubMed ID: 34125219
[TBL] [Abstract][Full Text] [Related]
13. Effect of Medicaid Policy Changes on Medication Adherence: Differences by Baseline Adherence.
Amin K; Farley JF; Maciejewski ML; Domino ME
J Manag Care Spec Pharm; 2017 Mar; 23(3):337-345. PubMed ID: 28230447
[TBL] [Abstract][Full Text] [Related]
14. Medication Adherence, Health Care Utilization, and Costs Among Patients Initiating Oral Oncolytics for Multiple Myeloma or Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
Dashputre AA; Gatwood KS; Gatwood J
J Manag Care Spec Pharm; 2020 Feb; 26(2):186-196. PubMed ID: 32011965
[TBL] [Abstract][Full Text] [Related]
15. Adherence and persistence to prescribed medication therapy among Medicare part D beneficiaries on dialysis: comparisons of benefit type and benefit phase.
Park H; Rascati KL; Lawson KA; Barner JC; Richards KM; Malone DC
J Manag Care Spec Pharm; 2014 Aug; 20(8):862-76. PubMed ID: 25062080
[TBL] [Abstract][Full Text] [Related]
16. Impact of brand drug discount cards on private insurer, government and patient expenditures.
Law MR; Chan FKI; Harrison M; Worthington HC
CMAJ; 2019 Nov; 191(45):E1237-E1241. PubMed ID: 31712357
[TBL] [Abstract][Full Text] [Related]
17. Integrating E-Prescribing and Pharmacy Claims Data for Predictive Modeling: Comparing Costs and Utilization of Health Plan Members Who Fill Their Initial Medications with Those Who Do Not.
Chang HY; Kan HJ; Shermock KM; Alexander GC; Weiner JP; Kharrazi H
J Manag Care Spec Pharm; 2020 Oct; 26(10):1282-1290. PubMed ID: 32996394
[TBL] [Abstract][Full Text] [Related]
18. Using Previous Medication Adherence to Predict Future Adherence.
Kumamaru H; Lee MP; Choudhry NK; Dong YH; Krumme AA; Khan N; Brill G; Kohsaka S; Miyata H; Schneeweiss S; Gagne JJ
J Manag Care Spec Pharm; 2018 Nov; 24(11):1146-1155. PubMed ID: 30362915
[TBL] [Abstract][Full Text] [Related]
19. Impact of a transition to more restrictive drug formulary on therapy discontinuation and medication adherence.
Shirneshan E; Kyrychenko P; Matlin OS; Avila JP; Brennan TA; Shrank WH
J Clin Pharm Ther; 2016 Feb; 41(1):64-9. PubMed ID: 26778812
[TBL] [Abstract][Full Text] [Related]
20. Factors Associated with Adherence to Adjuvant Endocrine Therapy Among Privately Insured and Newly Diagnosed Breast Cancer Patients: A Quantile Regression Analysis.
Farias AJ; Hansen RN; Zeliadt SB; Ornelas IJ; Li CI; Thompson B
J Manag Care Spec Pharm; 2016 Aug; 22(8):969-78. PubMed ID: 27459660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]